Clinical trial

Study in Leptomeningeal Metastases of Breast Cancer

NCT03252912

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention blood samples Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study in Leptomeningeal Metastases of Breast Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-01-06

PhaseNA

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

blood samplesBIOLOGICAL

Sponsors & collaborators

Institut du Cancer de Montpellier - Val d'Aurellelead sponsor

Mapped research locations

MontpellierFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03252912 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.